Free Consultation

Mass Torts

Chemical Hair Straightener Lawsuit: Filing for Uterine Cancer Claims

If you’ve been using chemical hair straighteners or relaxers, you might have a higher chance of developing uterine cancer. Studies have found that these products often contain harmful chemicals like formaldehyde and phthalates, which can mess with your hormones and increase the risk of cancers like uterine and breast cancer. Many women who’ve used these products regularly are now sharing their experiences and joining a chemical hair straightener lawsuit to hold manufacturers accountable. At Ethen Ostroff Law, we’re breaking down the risks tied to these products, the lawsuits happening now, and how to find out if you can file a claim.

Click for Free Case Evaluation

Get Your Free Case Review

Find out if you qualify for compensation and learn your next steps – no cost, no obligation, just expert legal guidance.

Disclaimer: By submitting the form above and checking the consent box, you agree to our conditions and privacy policy and permit Ethen Ostroff Law to contact you via text messages, phone calls. Standard message rates may apply.


Get Your Free Case Review

Find out if you qualify for compensation and learn your next steps – no cost, no obligation, just expert legal guidance.

Disclaimer: By submitting the form above and checking the consent box, you agree to our conditions and privacy policy and permit Ethen Ostroff Law to contact you via text messages, phone calls. Standard message rates may apply.


Hair Relaxers for Personal Style and Beauty

Hair is every woman’s crowning glory. Throughout history, hair has held a special place in women’s lives. It symbolizes femininity, beauty, status, style, health, and personality. Women use their hair to express themselves in styles influenced by the fashions of their culture. Now, the choice to straighten hair is personal, as is the desire to transform one’s appearance.

When it comes to hair styling, using hair relaxers is all about having the versatility to go from textured to straight and back to textured again. Several companies have made hair straightening tools to alter the hair’s structure to aid in this process. Some of the most recognizable products are hair irons and chemical hair straighteners. They are proliferated and widespread. While the number of women who chemically straighten their hair continues to fall, most women with textured hair continue to do so periodically.

Some patients confess that they suffered from brain injuries after bumping their heads and suffering unusually heavy internal bleeding. However, in some of the Plavix lawsuits, the patients died.

Plavix was ineffective in about 25% of the plaintiffs. However, it has been found that it was no more effective than aspirin.

The patients have filed cases against the manufacturer of Plavix. The charges were:

  • Negligence.
  • False or misleading advertising.
  • Wrongful death.

People said that the manufacturer was aware of some of the potential health risks associated with Plavix class action when the FDA approved the drug. However, the drug manufacturer concealed this information.

Uterine Cancer and Chemical Hair Straighteners

There’s been growing concern lately about the possible connection between chemical hair straighteners and uterine cancer. Studies suggest that ingredients commonly found in hair relaxers, such as formaldehyde and other chemicals that affect hormone balance, might increase the risk of developing uterine cancer and other reproductive health issues.

For years, millions of women—especially those with textured hair—have turned to these products to get straight, sleek hair. While these products offer a quick way to change hair texture, their long-term use is raising red flags because of the chemicals they contain. These chemicals have the potential to mess with the body’s hormone regulation, which is a big worry for women who have used these products regularly over the years.

The link between hair straighteners and uterine cancer has caught a lot of attention, especially after studies found that women who used them often had higher rates of cancer. The concern is even more serious for those who’ve been exposed to these chemicals over many years.

Here’s a quick look at some of the studies that raised the alarm:

  • National Institute of Environmental Health Sciences: A study found that women who used chemical hair straighteners more than four times a year had a significantly higher risk of uterine cancer. It pointed out that the chemicals in these products—like formaldehyde, which is a known carcinogen—could be behind the increased risk.
  • Journal of the National Cancer Institute: Another study from this journal revealed that women who regularly used hair relaxers were more than twice as likely to develop uterine cancer compared to those who didn’t use these products.
  • Epidemiological Research on Hair Care Products: A broader study on hair care products found that chemical relaxers were among the highest contributors to cancer risk. It highlighted how chemicals like phthalates and formaldehyde can disrupt hormones, which is linked to various cancers, including uterine cancer.
Get Free Consultation

Increased Hair Straightener Cancer Risk Among Black Women

While uterine cancer is generally rare, studies show that Black women are diagnosed with it more often than women from other racial and ethnic groups. One key factor in this higher rate is the use of chemical hair straighteners. Here are some studies that explore this connection:

  • National Institutes of Health Study: Black women made up just 7.4% of the study participants, but they accounted for nearly 60% of those using chemical hair straighteners. This shows a strong link between using these products and the higher rates of uterine cancer among Black women.
  • Hair Dye and Cancer Risk: One study looked at the use of permanent hair dye and found that Black women who used it regularly had a 60% higher risk of breast cancer, compared to just 8% for white women. Although this study focused on hair dye, it still points to a bigger issue with hair products and cancer risk among Black women.
  • Uterine Cancer and Hair Products: A significant study, Use of Straighteners and Other Hair Products and Incident Uterine Cancer found the first solid evidence linking hair straighteners to uterine cancer, especially endometrial cancer. It confirmed that hair relaxers are a major contributor to this increased risk.
  • Endocrine Disruptors in Hair Products: Research has shown that many chemical hair relaxers contain endocrine-disrupting chemicals like formaldehyde, which are among the highest contributors to cancer risks. These chemicals can mess with hormone levels, which is linked to cancers like uterine cancer.
  • Early Exposure and Increased Risk: Studies also revealed that Black women use hair straighteners at a rate four times higher than white women. The concern is that early and frequent exposure to these chemicals, especially during younger years when the scalp absorbs more, could have long-term health consequences.

Uterine Cancer

Uterine cancer starts in the uterus, which is a key part of the female reproductive system. It can be serious and even life-threatening. Uterine cancer is often found later when treatment is harder. Early detection is important for better treatment outcomes.

There are two main types of uterine cancer:

  • Endometrial Cancer: This is the most common type, with over 60,000 new cases in the U.S. each year. It begins in the lining of the uterus. If found early, it can usually be treated with a hysterectomy (removal of the uterus), although radiation or chemotherapy may be needed if it has spread. Risk factors include obesity, hormone imbalances, and prolonged exposure to estrogen without enough progesterone.
  • Uterine Sarcoma: This is rarer and more aggressive, making up just 2-5% of uterine cancer cases. It can spread quickly to other parts of the body, like the lungs or abdomen. Treatment typically involves surgery to remove the tumor, followed by chemotherapy or radiation to target any remaining cancer cells.

Both types are linked to hormonal imbalances.

Get Free Consultation

Risk Factors for Uterine Cancer

Some things can increase your chances of developing uterine cancer. While having one or more of these factors doesn’t mean you’ll definitely get it, it can raise your risk. Here’s a simple breakdown of the most common risk factors:

  • Hormonal Imbalance: When there’s too much estrogen in your body and not enough progesterone, it can cause the lining of your uterus to grow too thick, increasing the risk of cancer. This imbalance can happen because of conditions like PCOS, or from things like early periods, late menopause, or hormone therapy with estrogen alone.
  • Obesity: Being overweight or obese raises your risk of uterine cancer because extra fat tissue produces more estrogen, which can lead to abnormal growth in the uterus.
  • Age: Most cases of uterine cancer happen in women over 50, especially after menopause. The older you are, the higher your chances, as hormone levels change with age, which can cause abnormal growth in the uterus.
  • Family History and Genetic Conditions: If you have a family history of uterine cancer or other cancers, like colorectal cancer, your risk may be higher. Certain genetic conditions, like Lynch syndrome, can also increase your chances.
  • Endometrial Hyperplasia: This is when the lining of your uterus gets thicker than normal, usually because of too much estrogen. It’s a condition that can lead to uterine cancer, so if you have it, regular check-ups are important.
  • Previous Cancer Treatments: If you’ve had radiation treatment for cancer in the pelvic area, it could increase your risk of uterine cancer. The radiation can affect your uterus over time.
  • Diabetes: If you have type 2 diabetes, especially if you’re also overweight, your chances of developing uterine cancer are higher. Diabetes causes changes in your hormones that can increase your risk.
  • Tamoxifen Use: Tamoxifen, a drug used to treat or prevent breast cancer, can make the uterus more sensitive to estrogen. This could increase your risk of uterine cancer.
  • Menstrual History: If you had your first period before age 12 or went through menopause after age 55, you’re exposed to estrogen for a longer time, which can increase your risk.
  • Never Having Been Pregnant: Women who haven’t been pregnant may have a higher risk because pregnancy helps regulate estrogen levels and may lower the chances of uterine cancer.

It’s important to be aware and stay on top of regular screenings. Staying healthy and talking to your doctor can help manage some of these risks.

Symptoms of Uterine Cancer

Uterine cancer symptoms can vary, but there are some common signs to watch for. Early detection can make treatment more effective, so it’s important to pay attention to changes in your body.

Here are the key symptoms:

  • Abnormal vaginal bleeding between periods, after menopause, or heavier than usual periods. 
  • Pain in the lower abdomen or pelvic area, especially if it doesn’t go away or seems unusual. 
  • Unexplained weight loss without trying, particularly if it’s sudden or significant. 
  • Pain or discomfort during intercourse. 
  • Difficulty urinating, feeling the need to urinate more frequently, or discomfort while urinating. 
  • Unusual non-bloody, watery, or foul-smelling vaginal discharge. 
  • Periods become unusually heavy, longer than usual, or occur at unexpected times. 
  • Feeling extremely tired or weak without any obvious cause. 
  • Persistent bloating or swelling in the abdomen, especially when it doesn’t go away  
  • Constant or unexplained lower back pain that doesn’t seem to improve, particularly if it’s accompanied by other signs.

If any of these symptoms appear, it’s important to see a healthcare provider who can evaluate your condition and determine if further testing is necessary. Early detection plays a crucial role in effective treatment.

Treatments for Uterine Cancer

When it comes to treating uterine cancer, the approach depends on how far the cancer has spread and your overall health. Here are the main treatment options:

  • Hysterectomy: This is the most common treatment and involves removing the uterus. Sometimes, doctors will also remove the cervix, ovaries, fallopian tubes, and nearby lymph nodes. It can be done through traditional surgery or with less invasive methods, depending on your situation.
  • Radiation Therapy: Radiation is used to target and destroy cancer cells. There are two types: external beam radiation, where a machine directs radiation at the cancer from outside the body, and brachytherapy, where a small radiation source is placed directly inside the vagina near the cancer.
  • Chemotherapy: Chemotherapy uses strong medications to kill cancer cells. It can be taken orally or through an IV and is often used before or after surgery to lower the chance of the cancer coming back or to treat advanced cancer.
  • Hormone Therapy: This treatment lowers hormone levels in the body to slow down cancer growth. It’s typically used for more advanced cases where the cancer has spread beyond the uterus.
  • Targeted Therapy: Targeted therapy focuses on specific characteristics of the cancer cells to block their growth. It’s often combined with chemotherapy for more advanced stages of uterine cancer.
  • Immunotherapy: Immunotherapy helps the immune system recognize and fight cancer cells. It’s a newer option that’s being explored for more advanced cases of uterine cancer.
  • Clinical Trials: Clinical trials offer access to new treatments that aren’t yet widely available. These can provide additional options, especially if standard treatments aren’t working.
  • Complementary and Alternative Medicine: Some people use alternative treatments along with their main cancer care. However, it’s important to talk with your doctor before trying any of these to ensure they’re safe and won’t interfere with your main treatment.

Each treatment plan is personalized, so it’s essential to discuss options with your healthcare team to determine what’s best for you.

Reducing the Risk of Uterine Cancer

While there’s no guaranteed way to prevent uterine cancer, making certain lifestyle changes and taking proactive steps can lower your risk. Here are some things you can do:

  • Maintain a healthy weight: Obesity increases the risk of uterine cancer, so eating a balanced diet and staying active can help keep your weight in check.
  • Stay active: Regular exercise is beneficial. Aim for at least 150 minutes of moderate activity each week. Whether it’s walking, biking, or dancing, staying active can help lower your risk.
  • Eat a healthy diet: Fill your plate with plenty of fruits, vegetables, and whole grains, and try to cut back on red and processed meats. A healthy diet can go a long way in supporting your overall well-being.
  • Limit alcohol: It’s a good idea to stick to one drink per day if you’re a woman, and two if you’re a man. Cutting back or avoiding alcohol altogether can help reduce your risk.
  • Consider hormonal contraceptives: Birth control pills that contain both estrogen and progesterone can help balance hormones and lower the risk of uterine cancer.
  • Talk about progesterone therapy: If you’re taking estrogen, adding progesterone might help balance your hormones and lower your risk of uterine cancer.
  • Having children and breastfeeding: If you’ve had children or breastfed, you might have a lower risk of uterine cancer. These life events can naturally lower estrogen levels.
  • Genetic testing: If you have a family history of uterine or colon cancer, talk to your doctor about genetic testing for conditions like Lynch syndrome. Knowing your genetic risk can help you take early action.
  • Regular screenings: If you’re at higher risk, talk to your doctor about how often you should be screened for uterine cancer. Regular check-ups can help catch anything early.
  • Consider a hysterectomy: In some high-risk cases, a hysterectomy (removal of the uterus) might be considered as a preventive measure. Make sure to discuss this with your healthcare provider.

These steps help lower your risk. However, always consult your doctor about what’s right for your health.

Chemical Hair Straightener Lawsuit

Chemical hair straighteners, often used by people with textured hair, have been linked to an increased risk of uterine cancer and other serious health problems. These products typically contain harmful chemicals like phthalates and formaldehyde, which can mess with the body’s hormones. As a result, many women are now filing lawsuits, believing that their use of these products led to conditions like uterine cancer, ovarian cancer, and breast cancer.

Allegations in Chemical Hair Straightener Lawsuits

The lawsuits involving chemical hair straighteners are focused on a few main points:

  • Failure to Warn Consumers: Many of the lawsuits argue that the companies didn’t warn consumers about the risks of using these products over time, like the higher chances of developing uterine or ovarian cancer.
  • Targeted Marketing: The lawsuits claim that manufacturers specifically targeted Black women with these products, even though they might have known about the potential health risks.
  • Presence of Harmful Chemicals: A big part of the claims is that these hair straighteners contain chemicals like phthalates and formaldehyde, which can mess with hormones and contribute to health problems like cancer.
  • Negligence and Misrepresentation: Plaintiffs also argue that the companies were careless in how they made, tested, and marketed these products, and that they gave false information about how safe they were.

These allegations are central to the multidistrict litigation (MDL) consolidated in the Northern District of Illinois, which involves thousands of cases against major manufacturers like L’Oréal, SoftSheen-Carson, and Strength of Nature.

MDL 3060: In Re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation

MDL 3060 was created in February 2023 to handle lawsuits about hair straighteners and relaxers. The lawsuits claim these products contain harmful chemicals, like phthalates and formaldehyde, which have been linked to uterine, ovarian, and endometrial cancers. All the cases are being managed together in the U.S. District Court for the Northern District of Illinois, with Judge Mary M. Rowland overseeing the process. As of January 2025, nearly 9,820 lawsuits are part of the MDL. Plaintiffs argue that the manufacturers failed to properly warn consumers about the health risks, especially the chemicals that disrupt hormone regulation.

Chemical Hair Straightener Products Named in Lawsuits

Several popular hair straightener brands are facing lawsuits over claims that their products may increase the risk of uterine cancer. These lawsuits allege that harmful chemicals like phthalates and formaldehyde in the products contributed to serious health issues. Brands named in the lawsuits include:

  • SoftSheen-Carson (SSC) – Dark and Lovely 
  • L’Oréal – Mizani, L’Oréal Paris, Dark and Lovely 
  • Strength of Nature – Just For Me, Soft & Beautiful, Motions, and TCB Naturals

These brands have been linked to ongoing litigation, with plaintiffs claiming that the companies failed to warn consumers about the potential risks of using these hair straightening products.

 

Status of Chemical Hair Straightener Lawsuits

As of January 2025, the legal battle surrounding chemical hair straighteners continues to grow. Here’s an update on the current status of the lawsuits:

  • The MDL 3060 now includes nearly 9,649 active cases, with the total number of filings surpassing 10,000. 
  • Major companies named in the lawsuits include L’Oréal, SoftSheen-Carson, and Strength of Nature. 
  • Plaintiffs argue that these products contain dangerous chemicals like phthalates and formaldehyde, which could increase the risk of uterine cancer and other serious health problems. 
  • The discovery phase is moving forward, with written discovery expected to wrap up by February 28, 2025, and oral fact discovery scheduled to be completed by September 30, 2025. 
  • Judge Mary Rowland is working to implement a bellwether process, selecting a few cases to move ahead to trial. This will help assess the main legal arguments and evidence, potentially guiding future settlement talks. 
  • A proposed class action involving major manufacturers like L’Oréal USA and Revlon has been approved to move forward. The class action is seeking economic damages and funding for medical monitoring.

The litigation is still ongoing, and more developments are expected in the coming months.

Chemical Hair Relaxer Lawsuit Update – January 2025

At Ethen Ostroff Law, we’re dedicated to keeping our clients informed about significant updates regarding the ongoing hair straightener litigation. Below are the latest developments:

  • January 1, 2025: Key Developments in Hair Relaxer Lawsuits: The number of chemical hair relaxer lawsuits continues to rise, with the multidistrict litigation (MDL) now encompassing 9,649 active cases. This includes 161 new filings, reflecting growing concerns over these products’ safety and their alleged links to severe health conditions like uterine and ovarian cancers. U.S. District Judge Mary Rowland, who oversees the MDL, has established clear discovery timelines: written discovery will close by February 28, 2025, and oral fact discovery must be completed by September 30, 2025. These deadlines signify critical progress in the litigation process.

Judge Rowland has also allowed a proposed class action against major manufacturers, including L’Oréal USA and Revlon, to move forward. This class action seeks economic damages and medical monitoring for consumers, alleging that these companies failed to warn users about potential health risks. Scientific studies have further linked chemicals in hair relaxers to heightened cancer risks, driving more individuals to pursue claims. These developments highlight the growing scrutiny surrounding hair relaxer products and the litigation’s trajectory.

  • December 1, 2024: Key Updates in Hair Relaxer Lawsuits and Settlement Outlook: As of November 2024, approximately 9,500 federal and 300 state-level hair relaxer lawsuits have been filed across jurisdictions like Illinois, Georgia, New York, Pennsylvania, and Delaware. The MDL, centralized in the Northern District of Illinois, continues to see significant legal activity. Recent filings include a Georgia woman’s claim alleging that her mother’s prolonged use of hair relaxers led to uterine cancer and ultimately her death. Plaintiffs argue that manufacturers like L’Oréal USA, Inc. and SoftSheen-Carson LLC failed to adequately warn consumers about these risks. The litigation remains in a critical discovery phase, with plaintiffs pushing for the release of key documents related to a “uterine study” from Strength of Nature. Settlement estimates suggest payouts between $100,000 and $1.5 million per person, based on precedents in similar cases. These developments emphasize the challenges manufacturers and plaintiffs face as this litigation progresses.
  • November 1, 2024: NAACP Joins Fight Against Hair Relaxer Manufacturers: The NAACP has joined lawsuits in Georgia, California, and Illinois, amplifying efforts to hold hair relaxer manufacturers accountable for products linked to cancer and reproductive issues. Studies indicate that regular use of hair straightening products nearly doubles the risk of uterine cancer, disproportionately affecting Black women due to higher usage rates. Partnering with Singleton Schreiber, the NAACP has brought additional legal and communication resources to these cases. This collaboration aligns with calls from U.S. Representative Ayanna Pressley for FDA regulation of harmful chemicals in hair products. The organization’s involvement aims to protect Black women’s health and push for stronger federal regulations to prevent similar harm in the future.
  • October 1, 2024: Upcoming Court Ruling on Hair Relaxer Lawsuit Discovery Disputes: The next court hearing in the Hair Relaxer MDL 3060 is scheduled for October 10, 2024. It will likely focus on resolving ongoing discovery disputes and evaluating the progress of bellwether trials. Plaintiffs allege that defendants are delaying discovery, while a special master has been appointed to manage electronic discovery issues. These proceedings are expected to address motions related to incomplete submissions and disputes over Plaintiff Fact Sheets.
  • September 1, 2024: Federal Court Approves Partial MDL Fund: On August 22, 2024, the Northern District of Illinois issued an order allowing the establishment of a common benefit fund for the Hair Relaxer MDL. However, the court restricted assessments to cases within its jurisdiction, excluding non-MDL cases. Plaintiffs proposed an 11% assessment (8% for legal fees, 3% for expenses), which the court deemed reasonable. This ruling ensures resources for managing the complex litigation while protecting the rights of individual plaintiffs.
  • August 1, 2024: MDL Expands as Discovery Process Advances: The Hair Relaxer MDL now includes over 8,400 active cases. Discovery continues, with a special master overseeing electronic document production to ensure compliance. Motions to dismiss filed by defendants and discovery challenges remain key hurdles. The next court conference is set for August 29, 2024.
  • July 2, 2024: New Cases Filed at a Slower Pace: The pace of new filings has slowed, with the MDL growing modestly from 8,170 cases in June to 8,333 in July. Efforts to consolidate additional cases aim to streamline proceedings and ensure consistent rulings.
  • June 3, 2024: Review of Plaintiff Fact Sheets Underway: Plaintiffs in the MDL are required to submit completed Plaintiff Fact Sheets (PFS) to provide relevant information for their claims. Defendants allege that some plaintiffs have submitted incomplete or blank PFS forms, prompting disputes. The court has mandated compliance to prevent delays and ensure fairness in case selection for bellwether trials.
  • May 15, 2024: FDA Fails to Meet Formaldehyde Ban Deadline: The FDA failed to act on a proposed ban on formaldehyde in hair straightening products, despite its established links to cancer. This inaction has drawn criticism, particularly from advocacy groups representing Black women, who are disproportionately affected by these products.
  • May 1, 2024: Dispute Over Special Master: The court appointed Professor Maura Grossman as the MDL’s special master for electronic discovery, despite objections from defendants citing potential conflicts of interest. With over 8,400 pending cases, the MDL continues to address procedural and discovery challenges. This comprehensive update underscores the complexities of the hair relaxer litigation, which remains focused on addressing consumer harm and holding manufacturers accountable.
  • April 10, 2024: Voluntary Dismissals Dispute, Case Filings Slow, Plaintiff Fact Sheets Due: As the pace of new lawsuit filings slows, another group of Plaintiff Fact Sheets is expected next week. In the last 30 days, only 53 new cases joined the MDL, bringing the total number of hair relaxer lawsuits to 8,387. Some plaintiffs have requested to voluntarily dismiss or amend their complaints for various reasons before defendants provide answers. However, hair straightener manufacturers have opposed these dismissals, claiming they violate MDL rules.
  • March 4, 2024: Special Master Appointed, Defendants Push for Expense Limits, 117 New Cases Added to MDL: A Special Master was appointed in February to address complex litigation issues in the MDL. After a debate over potential candidates, retired Judge Paul Grimm was chosen. Defendants have requested capping his fees at $10,000 per month, equating to just 13 hours of work at his regular hourly rate, but plaintiffs’ lawyers have opposed this limitation. Additionally, only 117 new cases joined the MDL in February, bringing the total to 8,334 lawsuits.
  • February 6, 2024: Focus on 3 Cancer Types; MDL Sees 191 New Cases: The MDL now focuses on cases involving uterine, ovarian, and endometrial cancer, which are considered the strongest claims due to clear causation links. If you have developed one of these cancers after using hair straighteners, your case may have significant merit. With 191 new cases added in January, the total number of lawsuits has risen to 8,217. Although the surge in filings seen last summer has plateaued, new claims are still joining the MDL regularly.
  • January 19, 2024: Hair Relaxer Lawsuit Filings Show Signs of Plateau: Between December 2023 and January 2024, the monthly average of new filings steadily declined, suggesting a potential plateau in claims. However, eligible individuals can still file lawsuits with the assistance of experienced uterine cancer hair relaxer attorneys.
  • January 8, 2024: MDL Now Exceeds 8,000 Cases: The MDL now includes over 8,100 claims filed by individuals harmed by carcinogenic hair straighteners. Most cases remain pending as Judge Mary Rowland and the parties establish discovery protocols. Since its creation in February 2023, the MDL has seen a steady rise in filings, and we anticipate continued growth.
  • January 3, 2024: Court Examines Defendants’ International Sales: Judge Mary Rowland has permitted discovery into the international sales practices of hair relaxer manufacturers, despite dismissing Dermovia Skin Essentials, Inc., and Dubar International Limited from the litigation for lack of jurisdiction. This ruling emphasizes the court’s commitment to thorough fact-finding and accountability.
  • December 28, 2023: Study Finds Link Between Hair Relaxers and Uterine Cancer: A new study, part of the Black Women’s Health Study, has linked regular use of chemical hair relaxers to an increased risk of uterine cancer. Among 45,000 Black women surveyed, those using these products displayed a significant rise in cancer diagnoses, likely due to exposure to endocrine-disrupting chemicals.
  • December 18, 2023: Rising Plaintiff Numbers and Common Benefit Fund Proposal: The MDL now includes nearly 8,000 plaintiffs alleging harm from chemical hair straighteners. To support legal efforts, the court-appointed Leadership Development Committee has proposed an 11% common benefit fund to compensate attorneys. This rate, steep compared to similar mass torts, is under review.
  • November 13, 2023: Judge Rejects Motion to Dismiss Based on Preemption: Defendants argued that federal law preempts state law claims, seeking dismissal. Judge Rowland rejected this argument, allowing claims for failure to warn and negligence to proceed. Fraud-based claims were dismissed due to insufficient evidence, but punitive damage claims remain intact.
  • October 15, 2023: Plaintiffs Prevail in Discovery Dispute: Judge Rowland ordered defendants to comply with discovery requests by November 23, 2023, overruling their objections. This decision facilitates the timely progress of cases.
  • October 7, 2023: Short-Form Complaint Approved for MDL: Judge Rowland has approved a short-form complaint process, streamlining case filings into the MDL and allowing for more efficient case management.
  • October 1, 2023: 2,000 New Lawsuits Added to Hair Relaxer MDL: The MDL now includes over 2,000 chemical hair relaxer lawsuits, with many alleging that endocrine-disrupting chemicals caused uterine cancer. Television ads continue to raise awareness, fueling this fast-growing mass tort.
  • August 27, 2023: Status Conference Addresses Key Issues: A recent status conference addressed several issues, including a deadline for responses to defendant McBride’s motion to dismiss and Revlon’s bankruptcy-related concerns.
  • August 18, 2023: Master Complaint Filed in Hair Relaxer MDL: A nearly 400-page master complaint has been submitted, outlining shared allegations and expediting case filings. Plaintiffs must also file short-form complaints detailing unique claims.
  • August 1, 2023: MDL Surpasses 250 Cases: The MDL has grown to over 400 lawsuits, with advertising campaigns educating consumers about potential health risks linked to hair relaxers.
  • July 5, 2023: Defendants Push to Delay MDL Proceedings: Defendants requested a focus on causation issues to delay other discovery processes, but plaintiffs pushed back, emphasizing the need for a trial date to encourage settlement negotiations.
  • June 5, 2023: Causation Briefs Deadline: Parties must submit briefs outlining evidence that hair relaxers cause illnesses. Recent studies, including one from Boston University, have linked these products to fertility issues and racial disparities in health outcomes.
  • June 1, 2023: Discovery Procedures and Master Complaint Set: The MDL has addressed protocols for managing large volumes of evidence, with a master complaint facilitating streamlined filings. As of March, the MDL included 124 cases, with over 100 added in three months.
  • May 1, 2023: Plaintiffs Granted Direct Filing in MDL: Judge Mary Rowland has allowed direct filings into the MDL, simplifying the process and encouraging more cases to join this rapidly growing litigation.
  • February 8, 2023: Hair Relaxer MDL Established: The Judicial Panel on Multidistrict Litigation consolidated existing lawsuits into an MDL under Judge Rowland in the Northern District of Illinois. Despite opposition, the MDL aims to handle the growing number of claims efficiently.
  • January 26, 2023: Defendants Challenge Hair Relaxer MDL Formation: Arguments were presented before the Joint Panel on Multidistrict Litigation (JPML) regarding the MDL’s creation. Plaintiffs argued for efficiency, while defendants highlighted challenges, such as multiple brands and unclear chemical culprits. The MDL was ultimately established.
  • December 28, 2022: Defendants Oppose MDL for Hair Relaxers: Several defendants, including L’Oréal, Strength of Nature, Dabur, and House of Cheatham, have filed motions opposing the creation of an MDL for chemical hair relaxer uterine cancer lawsuits. They argue that the large number of defendants and different diseases involved would make consolidation inefficient. They also oppose the Northern District of Illinois as the venue for any MDL, with L’Oréal preferring the Southern District of New York instead.
  • December 17, 2022: Court Holds Arguments on Hair Relaxer Lawsuit Procedures: The JPML held oral arguments to decide if pending hair straightener uterine cancer lawsuits should be consolidated into a new MDL. Plaintiffs argue that the common legal and factual questions in these cases across federal jurisdictions warrant consolidation, which would streamline discovery and avoid conflicting rulings across different courts. MDLs are intended to reduce redundancy and simplify proceedings for mass tort cases.
  • December 11, 2022: Judicial Panel to Rule on Proposed Hair Relaxer MDL: The JPML has scheduled a hearing on January 26, 2023, to determine whether hair relaxer lawsuits filed in federal courts nationwide should be consolidated into a single jurisdiction. The defendants oppose this move, citing the number of involved defendants and products. However, many recent mass tort cases, including the Tylenol autism lawsuit, have been successfully consolidated into MDLs despite involving various defendants and products.
  • November 15, 2022: Plaintiffs Seek Consolidation of Hair Relaxer Lawsuits: A group of plaintiffs filed a motion with the JPML to consolidate all pending chemical hair relaxer lawsuits into a national MDL. The plaintiffs request that these cases be centralized in the Northern District of Illinois. Defendants, led by L’Oréal, are expected to oppose the consolidation due to the variety of products and defendants involved.
  • November 4, 2022: Hair Relaxer Class Action Lawsuit Filed: A class action lawsuit was filed in the Northern District of Illinois against L’Oréal, seeking class action status for the named plaintiffs and others similarly affected. The plaintiffs claim that the chemical hair relaxer products they used contained toxic endocrine-disrupting chemicals, and they would have avoided purchasing them if they had been warned. Notably, the plaintiffs have not yet been diagnosed with injuries but seek medical monitoring, including testing and preventative screening, due to concerns about their potential risk for uterine cancer, ovarian cancer, and uterine fibroids.
  • October 22, 2022: Chemical Hair Relaxer Lawsuit Gains Media Attention: A lawsuit was filed on behalf of Jenny Mitchell against L’Oréal, claiming that her regular use of L’Oréal’s Dark & Lovely hair relaxer caused her uterine cancer. This follows a study from the Journal of the National Cancer Institute, which found that women who used chemical hair relaxers at least four times a year were more than 2.5 times as likely to develop uterine cancer. This connection between hair care products and reproductive cancers is generating increasing attention.

These updates show the ongoing developments in the litigation surrounding chemical hair relaxers and their potential links to uterine cancer. Both plaintiffs and defendants are making key legal motions, and media attention is rising due to the studies and class action lawsuits involving these products.

How to File a Hair Relaxer Lawsuit for Uterine Cancer

If you think a hair relaxer might have contributed to your uterine cancer, here’s a simple guide on how to start a chemical hair straightener lawsuit:

  • Talk to a lawyer: The first thing you’ll want to do is reach out to a lawyer who focuses on product liability. They’ll help you determine if you have a case and explain the process.
  • Gather your information: You’ll need to gather some details about the hair relaxers you used, like the brand, product name, how often you used it, and for how long. Also, make sure you have medical records showing your cancer diagnosis and any related expenses.
  • Check if you qualify: Your lawyer will review everything and see if you meet the requirements to file a chemical hair straightener lawsuit, such as using a product from a brand involved in the case and being diagnosed with uterine cancer.
  • File the hair relaxer lawsuit: If you’re eligible, your lawyer will file the lawsuit for you, making sure it’s done on time.
  • Litigation process: Your uterine cancer lawsuit will be part of a larger group of cases in Illinois. The court will handle things like gathering evidence, holding trials, and settlement talks.
  • Settlement talks: If there’s a chance for a settlement, your lawyer will negotiate on your behalf to help get compensation for your medical bills, pain and suffering, and any other damages.

Who Can File a Uterine Cancer Lawsuit?

Here are the main criteria for filing a uterine cancer lawsuit related to hair relaxers:

  • Used a hair relaxer or chemical straightener. 
  • Used the product for at least five years in a row before diagnosis. 
  • Used it at least four times a year before diagnosis. 
  • At-home or salon use (or both) qualifies. 
  • Diagnosed with uterine cancer. 
  • Age at diagnosis was between 18 and 60. 
  • Diagnosis occurred between 2014 and now. 
  • Diagnosis happened within 10 years of last use. 
  • BRCA1 and BRCA2 test must be negative or unknown. 
  • No breast cancer diagnosis before the uterine cancer diagnosis.

     

If these points apply to you, you may have a valid case to pursue. Call Ethen Ostroff Law to ascertain eligibility.

Hair Straightener Brands That Could Be Held Responsible

If you’re thinking about filing a chemical hair straightener lawsuit, the company that made or sold the product could be held accountable. Figuring out who’s responsible often starts with the evidence you’ve gathered, like receipts or photos of the products you used.

Currently, some of the brands named in lawsuits include:

  • L’Oréal 
  • SoftSheen-Carson (Optimum Relaxer) 
  • Dark & Lovely 
  • Just For Me 
  • Motions Hair 
  • ORS Hair Care (Namaste Laboratories, LLC) 
  • African Pride (Godrej Group)

These are just some of the companies facing claims in the hair straightening products MDL. If you believe your health was affected by one of these brands, you might have a case.

What You'll Need to Prove a Chemical Hair Straightener Lawsuit

Strong evidence is key if you’re pursuing a chemical hair straightener lawsuit. Here’s what can help support your case:

  • Medical records: showing your diagnosis of uterine cancer or similar conditions. 
  • Treatment documentation: that details medical expenses and care related to your diagnosis. 
  • Proof of product use: like receipts or invoices for hair straightener purchases, photos or videos showing you using the products, testimony from stylists or loved ones who saw you use these products, and notes on how often and for how long you used them. 
  • Product packaging or labels: that show the exact brands and ingredients, like phthalates or formaldehyde. 
  • Expert opinions from doctors: linking your condition to harmful chemicals in the products. 
  • Scientific studies: that back up the connection between these hair straighteners and cancer risks. 
  • Evidence of manufacturer knowledge: like proof the company was aware of the risks but didn’t inform consumers.

Damages You Can Claim in Uterine Cancer Lawsuits

If you’re filing a uterine cancer claim, especially one linked to hair relaxer use, you may be eligible for various types of compensation. These damages reflect the full impact of uterine cancer on your life and your loved ones. Here’s an overview of what can be claimed:

  • Medical costs for treatments like surgery, chemo, or hospital stays. 
  • Lost income due to missed work or long-term disability. 
  • Pain and suffering from physical and emotional challenges. 
  • Reduced quality of life, including difficulty with daily activities. 
  • Emotional distress like anxiety or depression. 
  • Fertility-related damages, especially for younger individuals. 
  • Loss of companionship if it impacts your relationship with a spouse or partner. 
  • For families of victims, wrongful death damages like funeral costs or loss of support.

What to Look for in a Hair Straightener Lawsuit Lawyer

Choosing the right lawyer for your chemical hair straightener lawsuit is key, especially since you’re up against big cosmetic companies with strong legal teams. These companies will do everything they can to protect their profits, so you need an attorney who can stand up to them. Here’s what to look for:

  • Experience with product liability cases and suing large corporations. 
  • Resources to take on powerful cosmetic companies and their legal teams. 
  • A proven history of winning settlements or verdicts in similar cases. 
  • Clear and consistent communication throughout the process. 
  • Dedication to your case and a genuine understanding of what you’re going through.

A lawyer with these qualities can help you stand up to big companies and seek the compensation you deserve.

Get Help With Your Uterine Cancer Lawsuit

If you or a loved one has been diagnosed with uterine cancer after using chemical hair straighteners or relaxers, you may have a case. At Ethen Ostroff Law, we specialize in helping individuals affected by these products. Our hair relaxer lawyers offer free consultations to prospective clients and can help determine legal options for a chemical hair straightener lawsuit, including potential participation in a uterine cancer class action lawsuit. Call us today.

Frequently Asked Questions on Chemical Hair Straightener Lawsuit

The lawsuit is still in progress, and no settlements have been made yet. The case is expected to take a few years. Trials starting in late 2025 or early 2026 may help speed things up.

Chemical hair straightening can cause health risks, especially with long-term use. It’s important to be aware of these risks and consider safer alternatives.

You may qualify if you‘ve used chemical hair relaxers for a long time, have been diagnosed with uterine cancer or related conditions, and can provide proof of using the product, like receipts or photos. You should also have suffered significant losses because of your condition.

Payouts can range from $300,000 to $1.8 million, depending on the severity of the case. These amounts may change as the lawsuit moves forward.

Not all hair straighteners contain formaldehyde, but many products, like Brazilian blowouts, release formaldehyde gas during use. It may also be listed under different names, like formalin.

While no specific products are confirmed to cause cancer, research shows that chemical hair straighteners with ingredients like formaldehyde may increase the risk of uterine cancer.

Success

We received your information. We’ll be in touch soon.

Ok
While in law school, he distinguished himself as Executive Editor of JURIS Magazine, received the prestigious CALI Excellence for the Future Award, and completed five hands-on internships that laid a strong foundation for his legal career.


Nicholas began his post-graduate career clerking for the Honorable Linda Rovder Fleming in the Cambria County Court of Common Pleas. From there, he quickly found his calling in workers’ compensation, personal injury, and Social Security disability law—areas where he could directly impact people’s lives in moments of crisis. He’s helped clients navigate complex legal claims, including securing a settlement exceeding $300,000.

Nicholas brings clear communication, genuine empathy, and an unrelenting drive to achieve the best outcomes for his clients. Whether he’s navigating a complex workers’ comp claim or pushing for a major settlement, he brings focus, dedication, and deep legal knowledge to every case.

He’s also a proud member of Pennsylvania Advocates for Justice and remains active in various professional legal organizations. Nicholas is licensed to practice law in Pennsylvania.

When he’s not fighting for the injured, Nicholas is enjoying time with his family, kicking a soccer ball around, hitting the golf course, or cheering on Pittsburgh’s local teams.

Joe Ring heads the workers’ compensation department at Ethen Ostroff Law, where he takes pride in fighting for injured workers.

Joe is a Philadelphia native and maintains deep roots in the area.  As the grandson of a Philadelphia Firefighter, son of a Philadelphia public school teacher, and veteran of the United State Marine Corps, he was taught to value service, dedication, and hard work.   He applies these values to every case and takes great satisfaction in representing hard-working clients with those same traits.

After obtaining his bachelor’s degree in history from St. Vincent College in Western Pennsylvania, he graduated from Villanova Law School in 2012 and, since then, has litigated hundreds of workers’ compensation hearings and trial depositions on behalf of both employers and injured workers.  During this time, Mr. Ring has written articles and presented Continuing Legal Education courses on developments in Pennsylvania Workers’ Compensation Law.  He is active in local professional organizations, and, in 2022, he served a Co-chairperson of the Philadelphia Bar Associations Workers’ Compensation Section.

Since coming to EOL in 2024, he has dedicated his practice entirely to helping injured workers navigate the system and obtain their rightful benefits.

Joe is licensed to practice in Pennsylvania.

Brandon Zanan heads the personal injury claim department with Ethen Ostroff Law.

Brandon’s education in both law and medicine assist him in expertly representing badly injured victims. Brandon has a Master’s Degree in Forensic Medicine from the Philadelphia College of Osteopathic Medicine, with a concentration in anatomy and pathology. With this knowledge,  Brandon is skilled at analyzing medical records and understanding injuries that are common in personal injury claims. He uses this expertise in conjunction with listening carefully to each client’s needs, in order to fiercely advocate for clients and tell their stories when they would not otherwise have a voice.

Brandon’s background includes a variety of experience and skills in various areas of civil practice. He is the author and editor of numerous books for the George T. Bisel Publishing Company, including “Pennsylvania Damages” and the “Pennsylvania Vehicle Code Annotated,” two texts that are frequently relied on by lawyers and judges across Pennsylvania as authoritative resources on personal injury law.

Brandon is a member of the Pennsylvania and Montgomery Bar Associations. He is also a member of Pennsylvania Association for Justice, and has served as an executive board member of the Montgomery American Inn of Court.

He is admitted to practice in the Commonwealth of Pennsylvania, the United States District Courts for the Eastern District of Pennsylvania and Middle District of Pennsylvania, the State of New Jersey, the United States District Court for the District of New Jersey, and in the Commonwealth of Virginia. Brandon has represented many clients in motor vehicle, premises liability, animal bite, and products liability cases across Pennsylvania and New Jersey and has obtained outstanding results with millions of dollars recovered for his clients.

He has been named a Pennsylvania Rising Star from 2021 onward. The “Super Lawyers-Rising Star®”, list recognizes no more than 2.5 percent of attorneys in each state

Brandon currently lives in Malvern with his wife Rachel and their son Max.

Ethen Ostroff Law, PLLC Terms and Conditions

Effective Date: July 10, 2024

General Information

Welcome to the website of Ethen Ostroff Law, PLLC (“EO”). By accessing or using our website, you agree to be bound by these Terms and Conditions (“Terms”). If you do not agree with these Terms, please do not use our website.

Use

EO hereby grants you a non-exclusive, non-transferable, revocable, limited right and license to access and use the Site solely for your personal use in accordance with these Terms of Use. You shall not, in any way, otherwise copy, reproduce, distribute, transmit, display, perform, reproduce, publish, license, modify, create derivative works from, sell, or exploit the Site.

EO may at any time, for any reason, and without notice or liability: (a) modify, suspend, or terminate operation of or access to the Site and related services, or (b) change, revise, or modify the Site and affiliated services.

Messaging and Automated Calls

When you opt-in, you will receive text messages (SMS/MMS) on your mobile number. These messages may contain information about your case, and the message frequency may vary from user to user. Please note that message and data rates may apply. If you wish to opt out of this service, you can do so anytime by simply texting “STOP” to the phone number. Once you text “STOP” to us, we will send you an SMS to confirm that you have been unsubscribed. If you encounter any issues, you can reply with the keyword “HELP” to get assistance. Please be aware that carriers are not responsible for any delayed or undelivered messages.

By providing your phone number and submitting a form on our website, you consent to receive communications, including automated calls, texts, and pre-recorded messages, from EO and its affiliates. These communications may include updates about your case, promotional offers, and other information. You understand that these calls may be generated using automated technology, and that standard message and data rates may apply.

Your consent to receive automated calls is not a condition of any purchase or service. By checking the consent box on our contact form or by calling our firm, you agree to these Terms and Conditions and provide your written consent to receive these communications. You may opt out of these communications at any time by replying STOP to any text message or by contacting us at [insert contact information].

State-Specific Compliance

EO complies with all federal and state laws regarding automated calls and telemarketing practices. Certain states have additional restrictions on the use of automated dialing systems and pre-recorded messages. The following states have more restrictive regulations:

  • California: Requires prior express written consent for automated calls.
  • Florida: Requires prior express written consent for automated calls and texts.
  • New York: Requires prior express written consent for automated calls.
  • Texas: Requires prior express written consent for automated calls.

If you are a resident of one of these states, EO will obtain your prior express written consent before making any automated calls or sending pre-recorded messages to you.

By submitting a form inquiry or calling our firm, you agree to us contacting you, and your checking the box when submitting your form inquiry serves as written consent.

Information and Legal Disclaimer

The information contained in this website is for informational purposes only, and should not be construed as legal advice. Testimonials and case results contained in this website are for demonstrative purposes only, and do not constitute a guarantee of any particular outcome in a specific case.

By requesting a free consultation with Ethen Ostroff Law, PLLC, you agree to the following:

  • Any information I submit is for review only, and there will be no charge for the initial consultation.
  • I have not entered into an attorney-client relationship with Ethen Ostroff Law, PLLC until such time as a formal written Retainer Agreement is signed by myself and a representative of Ethen Ostroff Law, PLLC. There is no guarantee that Ethen Ostroff Law, PLLC will accept my case.
  • Any information received by Ethen Ostroff Law, PLLC, prior to the execution of a written Retainer Agreement, is not subject to the Attorney-Client Privilege and is not considered confidential.
  • Additional information may be requested in order for Ethen Ostroff Law, PLLC to make a decision on whether or not to accept my case.
  • Because no attorney-client relationship has been established, I will remain personally responsible to meet all necessary deadlines applicable to my claim, until such time as Ethen Ostroff Law, PLLC makes a final decision. I acknowledge that I have not received any representations or legal opinions with respect to any time frames or deadlines that may be applicable to my claim.

No Relationship or Obligation Arises from Use of the Site

The law differs in every jurisdiction, and you should not rely on any opinion except that of an attorney you have retained, who has a professional duty to advise you after being fully informed of all the pertinent facts, and who is licensed in the applicable state, and is familiar with the applicable law. Internet subscribers, mobile application users, and online readers should seek professional counsel about their legal rights and remedies. You should not act or refrain from acting on the basis of any information found on the Site. Any actions or decisions about your legal rights should be based on the particular facts and circumstances of your situation, and appropriate legal advice from an attorney retained directly by you. EO EXPRESSLY DISCLAIMS ALL LIABILITY WITH RESPECT TO ACTIONS TAKEN OR NOT TAKEN BASED UPON ANY INFORMATION OR OTHER CONTENTS OF THIS SITE. Viewing the Site, or communicating with EO by Internet e-mail or through the Site does not constitute or create an attorney-client relationship with anyone. The content and features on the Site do not create, and are not intended to create, an attorney-client relationship, and shall not be construed as legal advice. The content and features of the Site, including means to submit a question or information, do not constitute an offer to represent you or otherwise give rise to an attorney/client relationship.

THE SITE IS PROVIDED “AS IS”. EO MAKES NO WARRANTIES, EXPRESS OR IMPLIED, REGARDING THE SITE AND ONLINE SERVICES AND HEREBY DISCLAIMS ALL WARRANTIES OF ANY KIND OR NATURE, INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, AND NON-INFRINGEMENT. WITHOUT LIMITING THE FOREGOING, EO DOES NOT GUARANTEE THAT THE ONLINE SERVICES OR PRODUCTS WILL MEET YOUR REQUIREMENTS, OR WILL BE ERROR-FREE, UNINTERRUPTED, OR FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS, OR THAT ANY DEFECTS WILL BE CORRECTED.

Accounts

To use some features of the Site, you may be required to create an account. In connection therewith, you agree to provide and maintain true, accurate, current, and complete information about yourself. You are responsible for maintaining the confidentiality of the information you hold for your account login, including your password, and for all Submissions made from your account. You agree to notify us immediately of any unauthorized use of your login. EO may suspend access to your account if it suspects illegal or improper use, or for other reasons, such as for account management purposes, at its sole discretion.

Confidentiality is Not Guaranteed

Information sent to Ethen Ostroff Law, PLLC. via Internet e-mail or through the Site is not secure and is done on a non-confidential basis. EO may make reasonable efforts to keep communications private, but because of the nature of Internet communications and the absence of an attorney/client relationship, we cannot promise or guarantee confidentiality.

DISCLAIMER – This Site Does Not Provide Medical Diagnosis or Advice

The content provided on the Site, such as documents, text, graphics, images, videos, news alerts, pharmaceutical drug recalls, prescription medication history, or information on litigation concerning the foregoing topics, or other materials, is for informational purposes only. The information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult a physician for diagnosis and treatment of any medical condition or for any questions you may have regarding a health concern. Never disregard professional medical advice, alter a prescription plan in any way, or delay or refrain from seeking medical advice because of something you have read or seen on the Site. Links to other sites are provided for information only. Use of trade names is for identification only and does not constitute endorsement by EO.

Without limiting the generality of the foregoing, the Site may present information about pharmaceutical drug recalls, which is for information purposes only. Such information is not necessarily the most current information on the subject and may or may not be updated based on the last information concerning such recalls. Do not make any decisions regarding medication or medical providers based on information from the Site, including but not limited to information we provide about drug recalls.

EO Is Not Responsible for Content; Limitation on Liability

EO may periodically change, remove, or add the material on the Site without notice. This material may contain technical or typographical errors. EO DOES NOT GUARANTEE ITS ACCURACY, COMPLETENESS OR SUITABILITY. EO assumes no liability or responsibility for any errors or omissions in the contents of the Site. Your use of the Site is at your own risk. Under no circumstances shall EO or any other party involved in the creation, production, or delivery of the Site be liable to you or any other person for any indirect, special, incidental, or consequential damages of any kind arising from your access to, or use of, the Site. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW IN NO EVENT SHALL EO BE LIABLE FOR ANY SPECIAL, INDIRECT, OR CONSEQUENTIAL DAMAGES RELATING TO THIS MATERIAL, FOR ANY USE OF THIS WEBSITE, OR FOR ANY OTHER LINKED WEBSITE.

Third-party Web Sites

The Site contains links to third-party websites for the convenience of our users. EO does not endorse any of these third-party sites and does not imply any association between EO and those sites. EO does not control these third-party websites and cannot represent that their policies and practices will be consistent with these Terms of Use. If you use links to access and use such websites, you do so at your own risk. EO is not responsible for the contents or availability of any linked sites. These links are provided only as a convenience to the recipient. These Terms only apply to the Site and do not apply to any linked sites. We encourage you to read and understand the terms of use of any linked sites that you visit. Links do not imply that we sponsor, endorse, are affiliated with or associated with, or are legally authorized to use any trademark, trade name, service mark, design, logo, symbol, or other copyrighted materials displayed on or accessible through any linked site.

EO Clients

Only individuals who have entered into a mutually signed retainer agreement with EO are EO clients (“EO Clients”).

Legal and Ethical Requirements

EO has tried to comply with all legal and ethical requirements in compiling the Site. We welcome comments about our compliance with the applicable rules and will update the Site as warranted, upon learning of any new or different requirements.

Ethen Ostroff Law reserves the right to refer or sell leads that come through any of Ethen Ostroff Law’s marketing.

Ethen Ostroff Law also may sell leads on certain campaigns generated in association with third party marketing companies.

Governing Laws in Case of Dispute; Jurisdiction

These Terms of Use shall be governed by and construed in accordance with the laws of the State of Pennsylvania, USA, without regard to any choice of law principles. Any and all disputes arising hereunder shall be governed as set forth in the Arbitration section below.

Submissions

You are solely responsible for any information, content, or material you transmit to or through the Site (“Submissions”). You understand that Submissions are considered non-confidential and non-proprietary. Furthermore, you grant EO an unrestricted, irrevocable, perpetual, transferable, sublicensable, worldwide, royalty-free license to use, copy, reproduce, display, publish, publicly perform, transmit, and distribute any Submission, without compensation or accounting to you or anyone else. You represent and warrant that: (a) you have the right to submit the Submission to EO and grant the licenses as described above; (b) EO will not need to obtain licenses from any third party or pay royalties to any third party for its use of the Submission; (c) the Submission does not infringe any third party’s rights, including intellectual property rights and privacy rights; and (d) the Submission complies with these Terms of Use and all applicable laws and regulations.

EO takes no responsibility and assumes no liability for any Submission.

Arbitration

Any and all claims by you arising out of or related to the Site or your use thereof may be resolved only through a binding arbitration proceeding to be conducted under the auspices of the Commercial Arbitration Rules of the American Arbitration Association in Montgomery County, Pennsylvania. Both your agreement to arbitrate all controversies, disputes and claims, and the results and awards rendered through the arbitration, will be final and binding on you and may be specifically enforced by legal proceedings. Arbitration will be the sole means of resolving such controversies, disputes and claims, and you waive your rights to resolve such controversies, disputes and claims by court proceedings or any other means. You agree that judgment may be entered on the award in any court of competent jurisdiction and, therefore, any award rendered shall be binding. The arbitrator may not consolidate more than one person’s claims, and may not otherwise preside over any form of a representative or class proceeding. You understand that by agreeing to arbitration as a mechanism to resolve all controversies, disputes and claims between us, you are waiving certain rights, including the right to bring an action in court, the right to a jury trial, the right to broad discovery, and the right to an appeal. You understand that in the context of arbitration, a case is decided by an arbitrator (one or more), not by a judge or a jury.

International Use

The Site is controlled, operated, and administered by EO from offices within the United States of America and is only intended for use therein. We make no representation regarding use of the Site outside of the United States.

Other Terms

If, for any reason, our Terms of Use, Privacy Policy, or any portion thereof to be unenforceable, such provision shall be enforced to the maximum extent permissible so as to give the intended effect thereof, and the remainder of these Terms of Use and Privacy Policy shall continue in full force and effect. EO’s failure to act with respect to a breach by you or others does not waive our right to act with respect to that breach or subsequent or similar breaches. No consent or waiver by EO hereof will be deemed effective unless in writing. These Terms of Use, together with our Privacy Policy, as each is currently posted, constitute the entire agreement between EO and you with respect to your use of the Site and supersede all previous written or oral agreements relating to the subject matter hereof, that this agreement shall not supersede, restrict, or replace any agreements governing the attorney-client relationship between EO and EO Clients.

EO may, in its sole discretion and without prior notice, block and/or terminate your access to the Site and if we determine that you have violated these Terms of Use or other terms or agreements or that may be associated therewith or if you use the Site in a way that we deem, in our sole discretion, to be an unacceptable use.

Get Your Free Case Review

Find out if you qualify for compensation and learn your next steps – no cost, no obligation, just expert legal guidance.

Disclaimer: By submitting the form above and checking the consent box, you agree to our conditions and privacy policy and permit Ethen Ostroff Law to contact you via text messages, phone calls. Standard message rates may apply.